Geneva Advisors’s Ambev ABEV Stock Holding History

Geneva Advisors’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$228K	Sell	41,620 -27,316	-40%	-$156K	﹤0.01%	658
2017 Q1	$397K	Sell	68,936 -6,774	-9%	-$37.2K	0.01%	544
2016 Q4	$372K	Sell	75,710 -376	-0.5%	-$2.03K	0.01%	540
2016 Q3	$463K	Sell	76,086 -61,663	-45%	-$369K	0.01%	481
2016 Q2	$814K	Buy	137,749 +7,358	+6%	+$39.5K	0.02%	345
2016 Q1	$675K	Buy	130,391 +48,901	+60%	+$225K	0.01%	370
2015 Q4	$363K	Buy	81,490 +6,877	+9%	+$33.6K	0.01%	462
2015 Q3	$366K	Sell	74,613 -12,245	-14%	-$66.5K	0.01%	443
2015 Q2	$530K	Sell	86,858 -2,441	-3%	-$15.1K	0.01%	417
2015 Q1	$514K	Buy	89,299 +20,712	+30%	+$129K	0.01%	412
2014 Q4	$427K	Sell	68,587 -45,868	-40%	-$290K	0.01%	438
2014 Q3	$750K	Buy	114,455 +19,050	+20%	+$134K	0.01%	353
2014 Q2	$672K	Buy	95,405 +39,930	+72%	+$294K	0.01%	386
2014 Q1	$411K	Buy	55,475 +27,975	+102%	+$196K	0.01%	428
2013 Q4	$202K	Buy	+27,500	New	+$201K	﹤0.01%	468

Other funds holding ABEV

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geneva Advisors's ABEV Position: Q2 2017 in Review

Geneva Advisors reduced its Ambev (ABEV) stake by 40% in Q2 2017, selling an estimated $156K and leaving 41,620 shares worth $228K. The position accounts for ﹤0.01% of the portfolio, ranked #658.

Geneva Advisors first reported a position in ABEV in Q4 2013 and has held it in 15 quarters since. The position peaked at $814K in Q2 2016. 301 funds tracked by Wall St. Rank hold ABEV as of Q2 2017.

Geneva Advisors held 41,620 shares of Ambev worth $228K as of Q2 2017.
Geneva Advisors sold 27,316 Ambev shares in Q2 2017, an estimated $156K.
Ambev made up ﹤0.01% of Geneva Advisors's portfolio in Q2 2017, its #658 holding.
Geneva Advisors first reported a position in Ambev in Q4 2013 and has held it in 15 quarters since.
Geneva Advisors's Ambev position peaked at $814K in Q2 2016.
301 funds tracked by Wall St. Rank held Ambev as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.